402 related articles for article (PubMed ID: 15497107)
1. [Adjuvant therapy for colon cancer].
Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
[No Abstract] [Full Text] [Related]
2. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
Grothey A; Sargent DJ
J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
[No Abstract] [Full Text] [Related]
3. [Treatment of colonic cancer and follow up].
Belmonte-Montes C; Cosme-Reyes C
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():122-5. PubMed ID: 18277499
[No Abstract] [Full Text] [Related]
4. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
Medinger M; Steinbild S; Mross K
Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
[TBL] [Abstract][Full Text] [Related]
5. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
Chua YJ; Zalcberg JR
Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
[TBL] [Abstract][Full Text] [Related]
6. Treatment of colorectal cancer.
Påhlman L
Ann Chir Gynaecol; 2000; 89(3):216-20. PubMed ID: 11079791
[No Abstract] [Full Text] [Related]
7. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
Twelves C
Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
[No Abstract] [Full Text] [Related]
8. Adjuvant therapy of colon cancer: current status and future directions.
Chung KY; Saltz LB
Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
[TBL] [Abstract][Full Text] [Related]
9. Accrual delayed in adjuvant bevacizumab trial.
Tuma RS
J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
[No Abstract] [Full Text] [Related]
10. [Difference of colon cancer and rectal cancer-from the view of an oncological physician].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):321-3. PubMed ID: 20723426
[No Abstract] [Full Text] [Related]
11. Overstated conclusions of a pooled analysis of bevacizumab in colon cancer.
Goffin JR; Talavera JR
J Clin Oncol; 2006 Jan; 24(3):528-9; author reply 529-30. PubMed ID: 16421433
[No Abstract] [Full Text] [Related]
12. Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases.
Prescrire Int; 2006 Jun; 15(83):109-1. PubMed ID: 16764102
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for colon cancer: a historical perspective.
Grem J
J Natl Cancer Inst; 2004 Aug; 96(15):1116-7. PubMed ID: 15292377
[No Abstract] [Full Text] [Related]
14. [Adjuvant therapy for colon cancer].
Moiseenko VM; Orlova RV
Vopr Onkol; 1998; 44(6):741-5. PubMed ID: 10087982
[No Abstract] [Full Text] [Related]
15. Adjuvant chemotherapy for colon and rectal cancer.
Fuchs CS; Mayer RJ
Semin Oncol; 1995 Oct; 22(5):472-87. PubMed ID: 7570058
[No Abstract] [Full Text] [Related]
16. Effects of 5-fluorouracil adjuvant treatment of colon cancer.
Kelder W; Hospers GA; Plukker JT
Expert Rev Anticancer Ther; 2006 May; 6(5):785-94. PubMed ID: 16759168
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy in stage II colon cancer: current approaches.
Baddi L; Benson A
Oncologist; 2005 May; 10(5):325-31. PubMed ID: 15851790
[No Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy for stage II colon cancer: the time has come.
Mamounas EP
Eur J Surg Oncol; 2000 Dec; 26(8):725-9. PubMed ID: 11087634
[No Abstract] [Full Text] [Related]
19. Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment.
Kornmann M; Formentini A; Ette C; Henne-Bruns D; Kron M; Sander S; Baumann W; Kreuser ED; Staib L; Link KH
Eur J Surg Oncol; 2008 Dec; 34(12):1316-21. PubMed ID: 18313881
[TBL] [Abstract][Full Text] [Related]
20. [Multimodal therapy for colon cancer: state of the art].
Weber T; Link KH
Zentralbl Chir; 2011 Aug; 136(4):325-33. PubMed ID: 21863510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
